Respiratory syncytial virus (RSV) is the most common pathogen of viral pneumonia in children, which occurs mostly in newborns and infants less than 6 months old, as well as in immunodeficiency patientsRead More…
Analysis of Vaccine Reviews-Episode II
1. Type of vaccine Advances in virology, molecular biology, and immunology have created many alternatives to traditional vaccines. Modern vaccines include nucleic acid (mRNA, DNA) vaccines, viral vector vaccines, virus-like particles andRead More…
Analysis of Vaccine Reviews-Episode I
Vaccines can greatly prevent infectious diseases. Between 1924 and 2010, 103 million childhood diseases were prevented in the United States through vaccination alone. In particular, smallpox was eliminated by vaccines in 1980,Read More…
Science: Human Antibody Response to Novel Coronavirus is Beneficial to the Development of Vaccine
A tool designed to detect the history of viral infection from a drop of blood has been upgraded in the COVID-19 era. VirScan is a technique that determines which of more thanRead More…
Nature: Mouse-adapted SARS-CoV-2 model lays the foundation for testing drugs and vaccines
In a new study, researchers from the University of North Carolina at Chapel Hill and other research institutions have developed a new COVID-19 mouse model that reproduces many of the features ofRead More…
Melanoma Combination Therapy: mRNA Cancer Vaccine and Immune Checkpoint Inhibition
MRNA is a kind of nucleic acid molecule that carries genetic information. MRNA vaccine transduces genetic information into the body and produce corresponding antigens, which can induce neutralizing antibodies and stimulate TRead More…
New Research: novel coronavirus’s evolution clues
According to a new virological research paper published in Nature-structure and Molecular Biology, a professional academic journal of Springer Nature, through a comparative study on the structure of the novel coronavirus (SARS-CoV-2)Read More…
Russia has developed intranasal novel coronavirus vaccine
Mark Shotov, director of the “Vector” National Virology and Biotechnology Research Center of the Russian Federation’s Consumer Rights Protection and Public Welfare Supervision Agency, said the center had developed an intranasal novelRead More…
Lancet Infect Dis: MERS coronavirus vaccine is expected to treat MERS
Recently, researchers have found that a Middle East respiratory syndrome coronavirus vaccine has shown efficacy in human trials, which may help to develop a vaccine against the new virus. Professor Marylyn Addo,Read More…
mRNA vaccine of SARS-CoV-2 is under development
Sanofi Pasteur recently announced the development of a new mRNA vaccine for COVID-19. In February, Sanofi Pasteur announced that it would begin to develop a recombinant protein candidate vaccine for COVID-19. DavidRead More…